Quoin Pharmaceuticals, Ltd.
QNRX
$5.91
-$0.16-2.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -88.14% | -68.02% | -87.23% | -63.80% | -12.75% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | -2.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.09% | -25.53% | -14.35% | 40.13% | 31.90% |
| Change in Net Operating Assets | -333.95% | 1,583.63% | 24.28% | 36.61% | 84.87% |
| Cash from Operations | -125.13% | -2.12% | -83.66% | -80.86% | 30.62% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -254.54% | -2.42% | -46.67% | 162.03% | -220.21% |
| Cash from Investing | -254.54% | -2.42% | -46.67% | 162.03% | -220.21% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Issuance of Common Stock | 203.74% | -100.00% | -100.00% | -96.84% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 208.90% | -0.07% | -10.05% | -99.57% | 3,342.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 292.26% | -40.21% | -312.89% | 135.02% | 166.47% |